Results 71 to 80 of about 190,274 (201)
Oral histiocytic sarcoma in a cat
Case summary A 15-year-old neutered male domestic shorthair cat presented with a 4-week history of dysphonia and reluctance to chew hard food. Oral examination revealed a mass lesion on the caudal soft palate. Biopsy was performed and histopathology with
Slavomίra Néčová +3 more
doaj +1 more source
A 9‐year‐old intact female chinchilla (Chinchilla lanigera) was presented to a referring veterinarian due to small, multiple cervical nodules that had been rapidly increasing in size and number.
Kaoru Enomoto +2 more
doaj +1 more source
WHO classification of skin tumours: key updates in the fifth edition
This review article summarizes the key updates in the 5th edition of the WHO Classification of Skin Tumours. It provides an overview of the major changes and new entities specific to the skin section, covering areas such as epidermal, melanocytic, mesenchymal and other tumours. The 5th edition of the World Health Organization Classification of Tumours (
Gabrielle Goldman‐Lévy +29 more
wiley +1 more source
Some epidemiological characteristics of malignant fibrous histiocytoma in the Province of Vojvodina [PDF]
BACKGROUND: Malignant fibrous histiocytoma is most common soft tissue sarcoma occurring in late adult life, most in the extremities and in the retroperitoneum, usually developing in deep fascia or skeletal muscle.
Dugandžija Tihomir +4 more
core +1 more source
Objectives To assess the prevalence and factors associated with increased caregiver burden among owners of dogs and cats undergoing anti‐cancer therapy in Hong Kong. Materials and Methods Clients of the oncology service of a large veterinary hospital in Hong Kong completed an online survey during real‐time consultations.
K. M. Tam +3 more
wiley +1 more source
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition [PDF]
Resistance to the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib has been attributed solely to mutations in BTK and related pathway molecules. Using whole-exome and deep-targeted sequencing, we dissect evolution of ibrutinib resistance in serial ...
Lander, Eric Steven
core +1 more source
Background Histiocytic sarcoma (HS) is a rare hematopoietic malignancy with an aggressive clinical presentation associated with a poor overall survival.
Zijian Liu +7 more
semanticscholar +1 more source
Evaluating VEGFR2 as a Target for Anti‐Tumour Therapy in Canine Melanoma
ABSTRACT Vascular endothelial growth factor receptor 2 (VEGFR2) is a key target for anti‐angiogenic oncotherapy, as inhibiting this receptor on tumour vasculature slows tumour development and enhances drug‐ and immune infiltration, improving therapy outcome.
Esther Hindriks +5 more
wiley +1 more source
Langerhans´cell histiocytosis [PDF]
La histiocitosis de células de Langerhans (HCL), anteriormente conocida como histiocitosis X, es una enfermedad poco frecuente caracterizada por la acumulación y proliferación de histiocitos, eosinófilos y células de Langerhans, con inclusión de gránulos
Casanovas, A., Elena, G., Rosso, Diego
core +1 more source
Multifocal histiocytic sarcoma of the gastrointestinal tract
We report a rare case of extranodal histiocytic sarcoma with multifocal gastrointestinal tract involvement, which has not been documented in the literature so far.
Shirley Sundersingh +3 more
doaj +1 more source

